TCG CROSSOVER MANAGEMENT, LLC – Aerovate Therapeutics, Inc. Transaction History
TCG CROSSOVER MANAGEMENT, LLC portfolio value:
$15.91M
portfolio value
TCG CROSSOVER MANAGEMENT, LLC quarter portfolio value change:
+6.08%
quarter
Aerovate Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +7.87% | 70K shares | 2.00M | $16.58 | 959.57K |
| Q2 2022 | share | 0.00% | 0 shares | -2.40M | $15.63 | 889.57K | |
| Q1 2022 | share | Increase | +4.25% | 36.24K shares | 6.24M | $18.33 | 889.57K |
| Q4 2021 | share | Increase | 0.00% | 853.33K shares | 10.06M | $11.19 | 853.33K |